Thomas Suszynski, MD
Plastic Surgery · Minneapolis, MNNPI 1013336155
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medartis Inc. accounts for 63.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $4,172 and has fallen 95.5% since, to $187 in 2025.
Across 27 payments — averaging $245.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medartis Inc.$4K
- Medtronic$1K
- AbbVie$435
- Stryker$271
- Axogen$248
- Foundation Medical, LLC$220
- plus $189 from 5 others
What the payments were for
- Consulting fees$1,08016%
- Travel & lodging$2,19233%
- Food & beverage$3,34951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medartis Inc. | 10 | $4,179 |
| Medtronic | 1 | $1,080 |
| AbbVie(2 entities) | 5 | $435 |
| Stryker | 2 | $271 |
| Axogen | 2 | $248 |
| Foundation Medical, LLC | 2 | $220 |
| Trimed, Inc. | 1 | $71 |
| Johnson & Johnson | 1 | $53 |
| Mentor Worldwide LLC | 1 | $32 |
| Checkpoint Surgical, Inc | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APTUS$4,154
- VARIAX$310
- AVANCE NERVE GRAFT$229
- NATRELLE SALINE-FILLED BREAST IMPLANTS$146
- ALLODERM$117
- NATRELLE$117
- UNIVERSAL MANDIBLE$116
- VSP ORTHOGNATHIC$116
- VSP RECONSTRUCTION$116
How this compares
$6,621 in reported general payments places this provider in the 80th percentile of 106 plastic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 31 | $167 |
| Ondansetron Hcl | 55 | $148 |
| Cephalexin | 40 | $129 |
| Oxycodone Hcl | 49 | $110 |
| Meloxicam | 18 | $96 |
| Ciprofloxacin Hcl | 13 | $70 |
| Methocarbamol | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Minneapolis
- Douglas GervaisMinneapolis$11K
- Nicholas KimMinneapolis$9K
- Emma CordesMinneapolis$5K
- Mohammad Umar ChoudryMinneapolis$2K
- David ShaferRochester$1.5M
- Steven MoranRochester$277K
- Valerie LemaineBloomington$233K
- Craig JohnsonSaint Paul$54K
- Warren SchubertSaint Paul$24K
- Kitty WuRochester$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.